Vikas Srivastava
Consultant Anesthesiology and Critical Care, 167 Military Hospitals, Pathankot, IndiaPublications
-
Research
A Retrospective Study of Mortality Benefit Provided by Single Dose COVID Vaccine at Society Level during Second Wave of COVID at A Zonal Hospital
Author(s): Vikas Srivastava, Ahijit Banerjee, Harjot Singh and Sanjaya Kumar Gupta*
Introduction: Since December 2019, the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) pandemic has caused high morbidity and mortality, with new variants rapidly spreading. Vaccines to prevent corona virus disease 2019 (Covid-19) have been developed with unprecedented speed. Materials and Methods: An open, real-time, retrospective observational study was conducted at 167 Military Hospital, Pathankot. Data was available for 490 COVID 19 patients. The population of interest was 18-87 years old patients who were treated for moderate to severe COVID pneumonia irrespective of the vaccination status. Vaccination history was documented on admission. We also documented awareness regarding the name of covid-19 vaccine administered to the patients admitted in this hospital. Results: Between 08 Dec 2020, and 20 Jun 2.. Read More»